Skip to content

Determination of the optimal nutrient mix to acutely increase plasma ketones.

Determination of the optimal nutrient mix to acutely increase plasma ketones. - Acute Ketomix Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56805
Enrollment
24
Registered
2024-06-10
Start date
2024-08-08
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glucose intolerance Insulin resistance

Interventions

Participants will be asked to consume once a 25g MCT-based nutrient mix, once a 25g MCT-based nutrient mix + cofactors, and once a non-ketogenic control nutrient mix. Participants will be randomly a

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Aged 60-80 years - Body Mass Index (BMI) 25-35 kg/m2 - Stable dietary habits (no weight loss or gain > 5 kg in the past 3 months)

Exclusion criteria

Exclusion criteria: - Type 2 diabetes - Pre-diabetes based on one or a combination of the following criteria: - Impaired Fasting Glucose (IFG): Fasting plasma glucose >= 6.1 mmol/l and 3 servings per day for man and >2 servings per day for woman - Unstable body weight (weight gain or loss > 5 kg in the last 3 months) - Previous enrolment in a clinical study with an investigational product during the last 3 months or as judged by the investigator which would possibly hamper our study results - Significant food allergies/intolerance (seriously hampering study meals) - Participants who do not want to be informed about unexpected medical findings - Blood donation during or within 2 months prior to the study

Design outcomes

Primary

MeasureTime frame
The primary study endpoint is plasma ketone levels (assessed via blood draws).

Secondary

MeasureTime frame
The explorative outcomes are energy expenditure (indirect calorimetry), substrate utilization (indirect calorimetry), plasma glucose (blood draw), plasma insulin (blood draw) and continuous interstitial ketone levels (continuous ketone monitor).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 14, 2026